Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced nephropathy].

Pietro Amedeo Modesti1, Francesco Burberi, Federico Moroni

  • 1Clinica Medica Generale e Cardiologia, Università degli Studi di Firenze. pa.modesti@dfc.unifi.it

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Brewery Waste to Sustainable Aquafeed: Harnessing <i>Nannochloropsis</i> Microalgae for Fishmeal-Free Gilthead Sea Bream Diets.

Aquaculture nutrition·2026
Same author

Assessment of double anaerobic threshold in trained subjects.

Respiratory physiology & neurobiology·2026
Same author

Autochthonous and Allochthonous Gut Microbes May Work Together: Functional Insights from Farmed Gilthead Sea Bream (<i>Sparus aurata</i>).

Animals : an open access journal from MDPI·2026
Same author

Dietary rayon microfibers differentially reshape rearing water and host associated microbiomes of farmed European sea bass (Dicentrarchus labrax).

Environmental microbiome·2026
Same author

Feeding for Well-Being: Porcine Blood Hydrolysate Supplementation Improves Metabolic and Welfare-Related Traits in Farmed Gilthead Sea Bream (<i>Sparus aurata</i>).

International journal of molecular sciences·2025
Same author

Enzymatic Hydrolysis of Porcine Blood as a Strategy to Obtain a Peptide-Rich Functional Ingredient.

International journal of molecular sciences·2025

Early detection of drug-induced nephropathy is key to kidney recovery. Recognizing patient risk factors and understanding drug nephrotoxicity are crucial for preventing advanced renal injury.

Area of Science:

  • Nephrology
  • Pharmacology
  • Internal Medicine

Background:

  • Drug-induced nephropathy is a significant cause of acute kidney injury and chronic renal insufficiency.
  • Early clinical signs of drug-induced nephropathy are often absent, leading to delayed diagnosis and treatment.
  • Patient comorbidities like diabetes mellitus, congestive heart failure, and older age increase susceptibility to kidney injury from medications.

Purpose of the Study:

  • To review the primary clinical manifestations of drug-induced nephropathy.
  • To highlight the importance of identifying modifiable patient risk factors for drug-induced kidney injury.
  • To discuss common mechanisms underlying drug-induced renal damage.

Main Methods:

  • Literature review of drug-induced nephropathy.

Related Experiment Videos

  • Analysis of clinical presentations and risk factors.
  • Examination of common nephrotoxic mechanisms.

    • Main Results:

    • Drug-induced nephropathy can present insidiously, often detected only upon significant decline in renal function.
    • Several drug classes possess nephrotoxic potential, necessitating awareness among healthcare providers.
    • Patient-specific factors substantially impact the likelihood and severity of drug-induced renal injury.

    Conclusions:

    • Understanding the clinical spectrum of drug-induced nephropathy is vital for timely intervention.
    • Individualized risk assessment is paramount to safely prescribing medications with known nephrotoxic potential.
    • Prompt recognition and management can reverse early-stage drug-induced kidney damage.